Researcher profile
Anna Lauritano
Affiliations
Organizations
Public evidence
6 connected articles
Early biomarkers in the presymptomatic phase of cognitive impairment: changes in the endocannabinoidome and serotonergic pathways in Alzheimer's-prone mice after mTBI.2024 · Europe PMCPreclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice.2023 · Europe PMCOlive oil-derived endocannabinoid-like mediators inhibit palatable food-induced reward and obesity.2023 · Europe PMCThe endocannabinoidome mediator <i>N</i>-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity.2022 · Europe PMCHedonic eating in Prader-Willi syndrome is associated with blunted PYY secretion.2017 · Europe PMCAn Orally Active <i>Cannabis</i> Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse.2016 · Europe PMC
Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.